STONKWHISPER
← Back to Intel
Insider ActivityHALO

Connaughton Bernadette, Director at HALOZYME THERAPEUTICS, INC., sold $108K of HALO

Updated Jun 18, 2026
Connaughton Bernadette Director
HALOZYME THERAPEUTICS, INC. · $HALO
$108K Total Value
1,625 Shares Traded
$66.21 Price / Share
43,669 Shares Owned After
2026-06-02 Filing Date

Transaction Details

InsiderConnaughton Bernadette
TitleDirector
CompanyHALOZYME THERAPEUTICS, INC.
TickerHALO
Transaction TypeSale
Transaction Date2026-06-01
Shares Traded1,625
Price Per Share$66.21
Total Value$108K
Filed Date2026-06-02
Accession Number0001159036-26-000072

Ownership Context

Shares Owned After Transaction43,669
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001159036-26-000072

Other Insider Trades — HALO

Other Trades by Connaughton Bernadette

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for HALO — HALOZYME THERAPEUTICS, INC. →

Whisper Score — HALO

34.17
Murmurs
Current Whisper Score

See full analysis for HALO →

Track HALO insider activity in real time on The Wire →

Get alerts when Connaughton Bernadette files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 18, 2026 at 07:05 UTC

Want real-time data? Access The Wire for live sentiment tracking.